TRANSLATIONAL CANCER RESEARCH:
BENCH, BEDSIDE AND COMMUNITY

22nd Annual International Symposium of the
Hunter College Center for Study of Gene Structure & Function

Hunter College, West Building, Room 714
East 68th Street at Lexington Avenue ( #6 subway)

Thursday, January 22, 2009

This symposium is dedicated to the memory of Erwin Fleissner PhD,
former Hunter Gene Center Director (1987-1998),
who made important contributions to cancer research throughout his career.

Additional CTSC member institutions: Memorial Sloan-Kettering Cancer Center,
Hospital for Special Surgery, Hunter College School of Nursing, Cornell University Cooperative Extension.
Collaborator: New York Academy of Sciences.

This event is FREE. Registration required at http://cancersymposium.hunter.cuny.edu or 212-396-6121
Submit poster abstract online by January 15, 2009. Prizes for best posters.

The Weill Cornell Medical College designates this educational activity
for a maximum of 5 AMA PRA Category 1 Credits™.
Physicians should only claim credit commensurate with the extent of their participation in the activity.

Morning Session, 9:00AM
Interfacing with Patients: Prevention to Treatment

Afternoon Session, 1:15PM
Molecular Targeted Pathways for Bettter Cancer Treatments

Robert Weinberg, PhD,Keynote Speaker
MIT and Whitehead Institute for Biomedical Research
Mechanisms of Malignant Progression

Michael F. Clarke, MD
Stanford Institute for Stem Cell and Regenerative Medicine
Consequences of Utilization of Stem Cell Pathways by Cancer Cells

Jill Bargonetti, PhD
Hunter College, City University of New York
Pharmacogenomics for Cancers with Compromised p53

Neil Bander, MD
Weill Cornell Medical College/ New York-Presbyterian Hospital
Targeted Treatment of Metastatic Prostate Cancer with a Radiolabeled Antibody

Remarks by: Sidney A. McNairy, Jr. (Director, Res. Infrastructure, NIH),
Jennifer J. Raab (President, Hunter College),
Robert P. Dottin (Director, Hunter Gene Center),
Julianne Imperato-McGinley (Assoc. Dean, Weill Cornell),
David Foster (Prof., Hunter College)

Supported by the National Institutes of Health, National Center for Research Resources, 
Research Centers in Minority Institutions - G12-RR-003037
and Clinical Translational Science Award - UL1RR024996

This activity has been planned and implemented in accordance with
the Essentials and Standards of the Accreditation Council for Continuing Medical Education
through the joint sponsorship of Weill Cornell Medical College and Hunter College of the City University of New York.
Weill Cornell Medical College is accredited by the ACCME to provide continuing medical education for physicians.

WCMC CME activities are intended to be evidence-based and free of commercial bias.
All faculty disclosures will be made at the time of the activity.